Qtorin 3.9% Rapamycin Anhydrous Gel
Cutaneous Venous Malformations
Phase II
Recruiting
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
Oct 17, 2024
―
Qtorin 3.9% Rapamycin Anhydrous Gel
Microcystic Lymphatic Malformation
Phase III
Recruiting
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations
Jan 16, 2024
―
Ptx-022
Microcystic Lymphatic Malformation
Phase II
Completed
Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
Sep 08, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Palvella Therapeutics (PI6) have in its pipeline
PI6 is currently developing the following drugs: Qtorin 3.9% Rapamycin Anhydrous Gel, Qtorin 3.9% Rapamycin Anhydrous Gel, Ptx-022. These drug candidates are in various stages of clinical development as the company works toward FDA approval.